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Objective: To estimate the future rate of primary total hip (THR) or knee (TKR) replacement in the UK to
2035 allowing for changes in population demographics and obesity.
Design: Using age/gender/body mass index (BMI)-speciﬁc incidence rates from a population-based
cohort study of 50,000 THR and 45,609 TKR patients from the UK Clinical Practice Research Datalink
(CPRD) between 1991 and 2010, we projected future numbers of THR and TKR using two models: a static,
estimated rate from 2010 applied to population growth forecasts to 2035, and a log-linear rate extrap-
olation over the same period. Both scenarios used population forecast data from the UK Ofﬁce for Na-
tional Statistics (ONS).
Results: Assuming rates of THR and TKR for 2010, and given projected population changes in age, gender
and BMI, the number of THRs and TKRs performed in the UK in 2035 is estimated to be, respectively:
95,877 and 118,666. By comparison, an exponential extrapolation of historical rates using a log-linear
model produces much higher estimates of THR and TKR counts in 2035 at 439,097 and 1,219,362
respectively. Projected counts were higher for women than men. Assuming a changing (rather than
ﬁxed) future BMI distribution increases TKRs by 2035 but not THRs.
Conclusions: Using historical rates and population forecasts we have projected the number of THR/TKR
operations in the UK up to 2035. This study will inform policymakers requiring estimates of future
demand for surgery. Incorporating future forecasts for BMI into projections of joint replacement may be
more relevant for TKR rather than THR.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.What is already known on this topic
Register data and published incidence rates from the UK show
an increasing trend in annual rates of total hip (THR) and knee
(TKR) replacement.
The most recently published projections of UK future rates
covered England only, and were based on a 10-year period of
hospital episode data from 1991 to 2001 and did not account for
changes in BMI or other important risk factors for arthroplasty.N.K. Arden, Botnar Research
Oxford OX3 7LD, UK. Tel: 44-
. Arden).
ternational. Published by Elsevier LWhat this study adds
Using population-based data over a 20-year period to 2010, two
methods of projection showwidely different estimates for the level
of hip and knee replacement in 2035.
Estimates of future incidence rates resulting from log-linear
models can be particularly sensitive to the choice of time period
used for estimation.
Based on changing population demographics (age, gender,
obesity) and a static rate of replacement at 2010 levels, approxi-
mately 96,000 THRs and 119,000 TKRs could be carried out in the
year 2035.
The Poisson (log-linear) method produces long-term estimates
for future levels of replacement which are arguably neither plau-
sible nor sustainable in terms of NHS capacity and funding levels.td. All rights reserved.
Fig. 1. HSE 1991 to 2010 e proportion of respondents by BMI group.
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Joint replacement surgery for both hip and knee is one of the
most common elective surgical procedures carried out in the UK 1.
It is well established as a cost-effective intervention for end stage
lower-limb joint disease2. The annual incidence rates of primary
total joint replacements have been growing steadily throughout the
1990s and have continued to rise since the year 20003. Recent data
from the National Joint Registry for England, Wales and Northern
Ireland (NJR) show that the number of primary total joint
replacement operations is still climbing with 75,366 hip and 76,497
knee procedures performed in the 12 months to April 20124. The
cost burden to the National Health Service (NHS) is considerable,
and although each primary THR and TKR procedure is estimated to
cost in excess of £70002, recent work using a cost-effectiveness
model for THR shows that when primary care costs are incorpo-
rated then the discounted cost is higher5. Policymakers require
estimates of future demand for these procedures but providing
accurate medium to long-term forecasts is difﬁcult given that
provision of the majority of surgical capacity is determined by
governments which necessarily have limits on their planning
horizons.
Given the lack of availability of accurate predictions for themore
relevant inputs to forecasting models, often researchers make use
of more pragmatic methods. Occasionally there are rare exceptions
where a more sophisticated modelling approach is employed6, but
this usually requires access to at least one population-based cohort
or survey dataset with long-term follow-up. A more common
approach is to base future projections on a ﬁtted model for
observed temporal trends derived from a set of high-quality
research data, and then to extrapolate into the future using an
appropriate linear or log-linear model. Sometimes these pro-
jections may incorporate published long-term population pro-
jections from national statistical organisations. In the ﬁeld of lower-
limb joint replacement, there have been few published articles over
the past 20 years describing future projections. At a national level,
the literature is concentrated around the United States 7,8, the
Nordic countries9, the United Kingdom10,11, the Netherlands12 and
Germany13.
The aim of this study was to use data from the Clinical Practice
Research Datalink (CPRD), combined with national population
forecasts from the Ofﬁce for National Statistics (ONS) to calculate
age-gender speciﬁc forecasts for the number of primary total hip
(THR) and knee (TKR) replacements in the UK between 2010 and
2035. A secondary, and novel, aim was to produce forecasts which
reﬂect the changing distribution of body mass index (BMI).
Method
Participants
We used data obtained from the Clinical Practice Research
Datalink (CPRD). The CPRD comprises the entire computerized
medical records of a sample of patients attending general practi-
tioners (GPs) in the UK covering a population of 6.5 million patients
from over 630 contributing practices chosen to be representative of
the wider UK population. GPs in the UK play a key role in the de-
livery of healthcare by providing primary care and referral to
specialist hospital services. Patients are registered with one prac-
tice that stores medical information from primary care and hospital
attendances. The CPRD is administered by the Medicines and
Healthcare products Regulatory Agency (MHRA).
The CPRD records contain all clinical and referral events in both
primary and secondary care in addition to comprehensive de-
mographic information, prescription data, and hospital admissions.Data is stored using Read and OXMIS codes for diseases that are
cross-referenced to the International Classiﬁcation of Diseases
(ICD-9). Read codes are used as the standard clinical terminology
system within UK primary care. Only practices that pass quality
control are used as part of the CPRD database. Deleting or encoding
personal and clinic identiﬁers ensures the conﬁdentiality of infor-
mation in the CPRD.
We identiﬁed all patients in the database with a diagnosis code
for total hip or knee arthroplasty from 1991 until the end of 2010.
Read codes were used to identify primary THRs and TKRs (see
online Supplementary Tables 1 and 2). Patients were included in
the analysis if aged 18 years or over at the time of the replacement.
Participant demographics including age, gender and BMI were
collated. The BMI used was the nearest pre-operative measurement
to the THR/TKR date. We also acquired data from the Health Survey
for England (HSE) for the purposes of constructing a denominator
to estimate BMI speciﬁc rates. Lastly, we obtained gender speciﬁc
population projections for the UK from the ONS covering the period
2011 to 203514, upon which to project the estimated THR and TKR
rates.Analysis e estimation
Firstly the CPRD data was used to estimate annual incidence
rates for THR and TKR for the years 1991e2010 inclusive. We used
standard log-linear regressionmodels to produce calendar year, age
and gender speciﬁc rates. These methods were used in our previ-
ously published research article on temporal trends in THR/TKR3,
but our aimwas to extend this to include rates additionally speciﬁc
to BMI.
The CPRD is supplied with person-time denominator for its
practice population which enables the construction of annual
incidence rates by age and gender, but not by BMI group. In order to
further apportion the CPRD-supplied person-time denominator by
BMI categories, we used data from the HSE covering the period
1991 to 2010 as a proxy for the change in the distribution of BMI in
the UK population (Fig. 1). Unweighted HSE datawas used, since we
only required approximate relative proportions among BMI groups
in order to estimate the linear trend in these proportions. The CPRD
Table II
HSE 1991 to 2010: number of subjects by gender, age, BMI
Total subjects Female Male
186,174 100,576 (54.0%) 85,598 (46.0%)
N % N %
Age group (years)
18e39 37,664 37.4% 32,527 38.0%
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year, age, gender and BMI, using the year-age-gender speciﬁc BMI
proportions obtained from the HSE data. Age was grouped into
those aged 18 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 79 and 80
years and above. Categories for BMI (in kg/m2) were less than 20, 20
to 24.9, 25 to 29.9, 30 to 39.9 and 40 and above. Rates for hips and
knees were estimated separately.
Before applying the estimated incidence rates to the ONS pop-
ulation forecasts, we used the BMI data obtained from the HSE data
to split the ONS age-gender speciﬁc forecasts by BMI group. Two
methods were used to split the ONS forecasts: BMI proportions
ﬁxed at 2010 levels, and BMI proportions increasing linearly based
on ordinary least squares regression estimates derived from the
HSE BMI data from 1991 to 2010. The second of these methods
produced group proportion estimates which, over the 25-year
forecasting timeframe, would have resulted in proportions
greater than one or less than zero for some of the age-gender-BMI
categories. We therefore employed a pragmatic method of
smoothing the BMI group proportions over the forecasting time-
frame by using a hyperbolic tangent function similar to the method
used in the Foresight report entitled ‘Tackling Obesity’15.
Analysis e projection
Separately, for hips and then knees, we used two different
projection methods on each of the two future UK population sce-
narios, described as follows. The ﬁrst projection method used THR/
TKR incidence rate estimates held at 2010 levels, applied to each of
the two population scenarios, while the second method used an
exponential extrapolation directly from the log-linear model esti-
mated rates for THR/TKR. The exponential extrapolation method is
included for comparison purposes. The two population forecast
datasets to which these rates were applied both contained exactly
the same population growth estimates by age and gender over
time, as forecast by the ONS. The difference between the two
population scenarios was that one population dataset assumed a
static BMI distribution, held ﬁxed at 2010 levels as estimated from
the HSE data, whereas the other reﬂected our HSE- and CPRD-based
estimates of forecast BMI distribution change in the UK population.
Thus the population forecast totals for each of the two datasets
were the same, the only difference being in the BMI proportions
used to split the forecast counts into age-gender-BMI speciﬁc totals
for each year up to 2035.
All statistical analyses were performed using SAS version 9.3
(SAS Institute Inc., Cary, NC), with PROC GENMODused for both log-
linear and linear regression model estimation.
Results
Within the CPRD data there were 50,000 patients undergoing
THR and 45,609 patients undergoing TKR between 1991 and 2010
for whom age, gender and BMI were recorded. The average age at
replacement was similar in both the THR and the TKR groups but
the proportion of women was greater for both THR and TKR
(Table I). Pre-operative BMI was slightly higher for TKR than THR.Table I
Demographic characteristics e CPRD subjects used to construct incidence rates
THR (N ¼ 50,000) TKR (N ¼ 45,609)
Female
(N ¼ 31,148)
Male
(N ¼ 18,852)
Female
(N ¼ 26,623)
Male
(N ¼ 18,986)
Age (mean, SD) 69.9 (10.9) 67.8 (10.7) 70.3 (9.5) 69.4 (9.2)
Gender (%) 62.2 37.8 58.4 41.6
BMI (mean, SD) 27.2 (5.1) 27.7 (4.2) 29.6 (5.4) 28.8 (4.4)The HSE data used to estimate the future BMI distribution
covered the period 1991 to 2010 and comprised 186,174 subjects
with BMI measured. A breakdown of this total by age, gender and
BMI group is given in Table II. The ONS population forecast data for
the UK14 to which our estimated incidence rates were applied are
based on 2010 estimates for the following 25 years, suggesting that
the UK adult population will grow from 49.0 million in 2010 to
approximately 58.5 million by 2035.
Under the static rate projection method, with the BMI distri-
bution held ﬁxed at levels estimated for 2010, the annual number of
THRs is forecast to grow to 95,877 by 2035, with TKRs growing to
118,666. Under the same projection method, but with the BMI
distribution changing according to our HSE-based forecast, THRs
grow to 97,536 and TKRs to 110,306.
Under the log-linear projection method, with the BMI distri-
bution held ﬁxed at levels estimated for 2010, the annual number of
THRs is forecast to grow to 437,708 by 2035, with TKRs growing to
439,097. With a changing BMI distribution THRs grow to 1,070,790
and TKRs to 1,219,362. Tables IIIa and b show ﬁve-yearly projections
for all four forecasting scenarios up to the year 2035.
For all results that follow, we present counts split by gender, BMI
and age which are only estimated using the static rate projection
method. Table IV shows projected TJR counts by gender for hip (IVa)
and knee (IVb). For THR, whenwe compare projectionwith ﬁxed or
varying future estimates of BMI category distribution, there is little
gender speciﬁc difference in counts at 2035. However, for knees
differences between methods exist, especially for women whose
TKR count at 2035 is estimated to be 9% higher when using varying
BMI distribution as opposed to ﬁxed.
Figure 2(a) and (b) shows projected THR counts for each cal-
endar year, split by BMI group, under the two assumptions for
future BMI distribution. Clear differences in the relative contribu-
tion of the major BMI categories are apparent, with the overweight
and obese groups having a greater proportion of the total THR
count whenwe allow the BMI distribution to change going forward.
Figure 3(a) and (b) shows the same for projected TKR counts.
Figure 4(a) and (b) shows the projected counts for THR and TKR
respectively, for each calendar year, split by age group in decades
(i.e., subject in his/her 40s, 50s, 60s, etc.)
Discussion
With this study we have combined data from three different
sources (CPRD, ONS and HSE) to estimate the future projected
count of THR and TKR operations in the UK up to the year 2035. The
estimates extend the methods of Kurtz and colleagues7 to add BMI40e49 18,503 18.4% 15,704 18.3%
50e59 15,620 15.5% 13,640 15.9%
60e69 13,813 13.7% 12,433 14.5%
70e79 10,430 10.4% 8504 9.9%
80 and over 4546 4.5% 2790 3.3%
BMI group (kg m2)
Below 20 6117 6.1% 2933 3.4%
20e25 39,261 39.0% 27,347 31.9%
25e30 33,361 33.2% 38,681 45.2%
30e40 19,688 19.6% 16,216 18.9%
40 and over 2149 2.1% 421 0.5%
Table IIIa
Projected UK counts for THR in adults to the year 2035
Projection scenario
Estimated THR incidence rates
ﬁxed at 2010 level
Estimated THR incidence rates
increasing log-linearly
BMI category
proportions ﬁxed
at 2010 estimates
BMI category
proportions
changing
over time
BMI category
proportions ﬁxed
at 2010 estimates
BMI category
proportions
changing
over time
2015 72,762 72,418 96,314 95,945
2020 79,716 79,048 141,626 140,945
2025 85,988 85,026 205,464 204,793
2030 91,496 90,202 296,354 296,106
2035 97,516 95,877 437,708 439,097
Table IIIb
Projected UK counts for TKR in adults to the year 2035
Projection scenario
Estimated TKR incidence
rates ﬁxed at 2010 level
Estimated TKR incidence rates
increasing log-linearly
BMI category
proportions ﬁxed
at 2010 estimates
BMI category
proportions
changing
over time
BMI category
proportions ﬁxed
at 2010 estimates
BMI category
proportions
changing
over time
2015 82,610 85,019 128,944 133,063
2020 90,555 94,783 221,653 234,244
2025 97,780 103,657 376,384 407,400
2030 103,810 111,015 632,257 701,052
2035 110,306 118,666 1,071,790 1,219,362
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mates which are speciﬁc to these three variables.
Apart from the work of Kurtz, there are few major large
population-level studies describing how future THR and/or TKR
incidence might change in future years. Over the past 20 years,
some examples exist outside the UK and US at national9,12,16,17 and
at regional18 level but arguably the best examples within the UK are
the studies by Dixon et al.11 in which data from HES was used toTable IVa
Projected UK counts for THR by gender to the year 2035 with estimated THR inci-
dence rates ﬁxed at 2010 level
Women Men
BMI category
proportions ﬁxed
at 2010 estimates
BMI category
proportions
changing
over time
BMI category
proportions ﬁxed
at 2010 estimates
BMI category
proportions
changing
over time
2015 45,143 44,905 27,618 27,513
2020 49,207 48,752 30,509 30,296
2025 52,949 52,307 33,039 32,719
2030 56,255 55,426 35,241 34,776
2035 59,909 58,850 37,607 37,026
Table IVb
Projected UK counts for TKR by gender to the year 2035 with estimated TKR inci-
dence rates ﬁxed at 2010 level
Women Men
BMI category
proportions ﬁxed
at 2010 estimates
BMI category
proportions
changing
over time
BMI category
proportions ﬁxed
at 2010 estimates
BMI category
proportions
changing
over time
2015 47,703 49,207 34,908 35,812
2020 51,931 54,638 38,624 40,145
2025 55,785 59,604 41,995 44,054
2030 58,919 63,665 44,891 47,350
2035 62,493 68,082 47,813 50,584
Fig. 2. Projected UK counts for THR to the year 2035 with estimated THR incidence
rates ﬁxed at 2010 level e by BMI group. (a) With BMI category proportions ﬁxed at
2010 estimates. (b) With BMI category proportions changing over time.estimate THR and TKR counts which were projected linearly over a
10 year period, and by Birrell et al.10 who used Swedish THR rates
imposed onto ONS population forecasts to project THR counts to
the year 2026. The Kurtz paper used Poisson regression, combining
forecasts from the US census bureau to estimate counts in age-
gender-race domains.
The main criticisms of such data-driven projections, including
our own, is that: (1) they do not involve any estimates of future
need from government or other planning authorities, and (2) they
do not incorporate supply-side constraints (e.g., availability of
surgeons; hospital units) into themodelling process. This is not due
to difﬁculties with the statistical technicalities of introducing such
information into the model, but is due to the lack of availability of
reliable data on future need or supply. Information on future de-
mand is hard to elicit and even if available, may be based on
Fig. 3. Projected UK counts for TKR to the year 2035 with estimated THR incidence
rates ﬁxed at 2010 level e by BMI group. (a) With BMI category proportions ﬁxed at
2010 estimates. (b) With BMI category proportions changing over time.
Fig. 4. Projected UK counts for total joint replacement to the year 2035 with estimated
THR incidence rates ﬁxed at 2010 level, with BMI category proportions changing over
time e by age group (a) Hip. (b) Knee.
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specialists in the forecasting of service provision. Supply-side data
is more predictable, at least in the short-term, but in the longer
term the unpredictability of the direction of healthcare policy in-
troduces more uncertainty. All the projection estimates presented
here are only a guideline to the possible future direction of THR/
TKR counts, having been constructed using three different sources
of data, each with their own degree of imprecision, and any interval
estimate about these counts is likely to be wide. This lack of pre-
cision about prediction is a common limitation of all such studies
estimating future projections.
A further limitation is that we only had available data from
England with which to estimate the BMI distribution for the UK
over the study period. Even though England accounts for almost85% of the UK population, our estimated BMI distribution is likely
overall to be little different to that of the UK. Comparisons between
countries show that Scotland does have a slightly higher obesity
prevalence than England, but for Wales and Northern Ireland the
prevalence is lower than in England19.
A limitation of approaches which extrapolate rates from log-
linear models is that rates are implicitly assumed to continue
exponentially increasing into the future, and the most recent data
from the NJR suggests that for the UK ratesmay be levelling off after
a period of prior expansion in capacity through, for example, the
introduction of specialist treatment centres. It has been suggested
that, once adjusted for patient willingness and ﬁtness for surgery,
the balance between provision of and need for TJR may be closer
than the true burden of disease might suggest20. For healthcare
planners, the static rate assumption is arguably a sensible one, and
D. Culliford et al. / Osteoarthritis and Cartilage 23 (2015) 594e600 599places the focus on addressing any additional capacity demands as
a result of changing demographics. This is especially true if we
accept that current rates are affordable.
One of the most striking differences in the results is that when
we use the full extrapolation scenario from the log-linear incidence
model gives estimated projected counts in 2035 for TKR of 1.2
million and for THR of 400,000. With the latest ﬁgures from the
National Joint Registry for England and Wales showing the annual
number of THRs and TKRs both in the mid-70,000s, and growing
slower over the past 5 years than the 5 years prior, it is hard to see
how future demand and supply will rise to meet these estimates.
What we can say is that the log-linear extrapolation-based esti-
mates are much more sensitive to differences in the trajectory of
past incidence rates than to the other two sources of data (ONS
population forecasts and HSE-based BMI distribution). Any log-
linear model will produce exponential growth (or shrinkage) and
over such a long timeframe this has the potential to produce pro-
jections which are widely different fromwhat might anecdotally be
deemed ‘sensible’.
Nevertheless, although we feel that our alternative scenario
(THR and TKR incidence rates to remain at 2010 levels, as estimated
by log-linear model) yields projected counts that are perhaps more
plausible (TKR of 119,000 and for THR of 96,000 by 2035), these
could be seen as underestimates, especially so in the case of THR.
Although this static rates model is unlikely to be accurate, the log-
linear rates model is even less likely to be either accurate or sus-
tainable and the answer is likely to lie between the two approaches.
The other key ﬁnding is that for THR, there is virtually no dif-
ference in projected counts whether we ﬁx our future estimates of
BMI category distribution at HSE-estimated 2010 levels, or vary
them in line with a linear extrapolation of our 20-year HSE-derived
BMI estimates. However, for TKR there is a difference, with the
latter method estimating over 8000 more TKRs at 2035 than the
former. Initially this difference of 7% for TKRs may appear striking,
as it is solely due to the estimated change in BMI distribution
moving forwards towards 2035. However, there is evidence that the
link between BMI and knee osteoarthritis is stronger than that for
the hip21e23. The evidence for BMI as a risk factor for hip osteoar-
thritis is more mixed24,25, and the fact that THR projection is
insensitive to changing BMI distribution (whereas TKR is not) may
be partly driven by the 2010 baseline BMI proﬁle, given that it
appears to be the proportion of obese subjects which is the
important factor for higher projections (Figs. 3 and 4).Conclusion
This study combines comprehensive data sources to project
future counts of THR and TKR procedures in the UK and is the ﬁrst
to model BMI to show an effect on future rates of TKR. It is hoped
that the principle of integrating BMI into models for future demand
of healthcare resources may be of use to healthcare planners where
such resources are sensitive to the distribution of BMI in the
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